Medications

Long-acting cabotegravir not necessarily cost-effective for PrEP

(HealthDay)—For men who have sex with men and transgender women (MSM/TGW) at very high risk for HIV (VHR), the benefits of long-acting injectable cabotegravir (CAB-LA) in terms of life expectancy do not necessarily justify ...

Diseases, Conditions, Syndromes

Australians are living longer due to lockdowns

Pandemic restrictions have led to longer life expectancy for Australians, a new study from The Australian National University (ANU) has found.

page 37 from 40